Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Return on Sales (2016 - 2017)

Rocket Pharmaceuticals' Return on Sales history spans 4 years, with the latest figure at 97.51% for Q2 2019.

  • For Q2 2019, Return on Sales changed N/A year-over-year to 97.51%; the TTM value through Jun 2019 reached 97.51%, changed N/A, while the annual FY2015 figure was 17.51%, 865.0% up from the prior year.
  • Return on Sales for Q2 2019 was 97.51% at Rocket Pharmaceuticals, up from 94.72% in the prior quarter.
  • Across five years, Return on Sales topped out at 97.51% in Q2 2019 and bottomed at 0.29% in Q1 2017.
  • The 4-year median for Return on Sales is 42.49% (2016), against an average of 46.27%.
  • The largest annual shift saw Return on Sales crashed -4889bps in 2017 before it crashed -383bps in 2018.
  • A 4-year view of Return on Sales shows it stood at 42.49% in 2016, then crashed by -59bps to 17.51% in 2017, then soared by 420bps to 90.97% in 2018, then grew by 7bps to 97.51% in 2019.
  • Per Business Quant, the three most recent readings for RCKT's Return on Sales are 97.51% (Q2 2019), 94.72% (Q1 2019), and 90.97% (Q4 2018).